Navigation Links
Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
Date:5/18/2009

Preclinical Study is Subject of Upcoming ASCO Presentation

BELLEVUE, Wash., May 18 /PRNewswire/ -- Light Sciences Oncology, Inc. (LSO) today announced that a new preclinical study has yielded evidence that the company's novel light-activated drug Aptocine(TM) (formerly Litx(TM)) may enhance anti-tumor immunity and prevent metastases. Results of the study will be presented in a poster session at the annual American Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, on May 30, 8:00 AM - 12:00 PM. The study was conducted by Dr. Sandra Gollnick at the Roswell Park Cancer Institute in Buffalo, New York.

"With mounting evidence that Aptocine may be an active immunotherapy in addition to its demonstrated ability to ablate tumors, this drug may offer greater benefit to cancer patients than initially contemplated. Dr. Gollnick's thorough and exhaustive study defines an immune effect in cancer which is unprecedented," said LSO's President and CEO Llew Keltner, M.D., Ph.D.

In the preclinical study, Aptocine was used to treat primary tumors and examine prevention of metastases in the 4T1 tumor model, an aggressive, spontaneously metastasizing murine mammary tumor model that mirrors human breast cancer. When grown in the mammary fat pad of BALB/c mice, untreated 4T1 tumors rapidly metastasize to the lung, liver, lymph nodes, and brain. Primary 4T1 tumors grown in mice were treated and animal survival was followed. To determine whether the therapy could enhance anti-tumor immunity and reduce metastases, the lymph node (LN) cells from treated and control mice were transferred to naive recipient mice. Recipients were challenged with a tumorigenic dose of 4T1 cells 3 days after adoptive transfer and primary and secondary tumor growth in the recipients was examined.

Key outcomes of the study include:

  • Aptocine treatment significantly prolonged survival in treated ani
    '/>"/>

SOURCE Light Sciences Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Study shines more light on benefit of vitamin D in fighting cancer
3. Bacteria See the Light
4. Quantum light beams good for fast technology
5. Free will takes flight: how our brains respond to an approaching menace
6. New MRI finding sheds light on multiple sclerosis disease progressio
7. RA Drugs Linked to Slight Skin Cancer Risk
8. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
9. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
10. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
11. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...INE, Calif., Dec. 1 Mas...imetry(TM) and Measure-Through Motion and Low Perf...e of its latest innovation -- Masimo Rainbow SET A...and continuous respiration rate (RRa(TM)) that is ...ance. Masimo Rainbow SET Acoustic Monitoring may ...
(Date:12/1/2009)... Craig Moskowitz, a fourth-year medical student at...o go into internal medicine to help fulfill an unm...k, NJ (PRWEB) December 1, 2009 -- Having distingui...censing examinations, Craig Moskowitz--a fourth-ye...dicine--knew he could go into any area of medicine...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to the Stemedic...) Board of Directors at the Company’s Novemb...(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD ...Inc. (“Stemedica”) Board of Directors .... Roger J. Howe, PhD, Executive Chairman for Steme...
(Date:12/1/2009)... Dec. 1 "The patient will see you ...Blue Cross and Blue Shield of Minnesota,s 10,000 e...rst Minnesotans - and the first in the continental.... Online Care Anywhere allows patients to access m...to a computer or picking up the phone. Blue Cross ...
(Date:12/1/2009)...tion from annual mammography screening may increas...lial predisposition to breast cancer, according to...the Radiological Society of North America (RSNA). ...reening is very important, but a careful approach ...creening young women, particularly under age 30," ...
Breaking Medicine News(10 mins):Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3Health News:Mammography may increase breast cancer risk in some high-risk women 2
...., Jan. 12 Alseres Pharmaceuticals, Inc. today a...ce from the NASDAQ Stock Market ("NASDAQ") that fo... value of its listed securities has been below the... comply with NASDAQ Marketplace Rule 4310(c)(3)(A)...
...w Have Access to Advanced Medical Expertise When F... NEW YORK, Jan. 12 Nippon Life Benefits, a leadin...ompanies, today announced that its members will ha... , , The new service will allow eligible employe...
... Va., Jan. 12, 2009 AMERIGROUP Corporation (NYSE:...he AMERIGROUP Public Policy Institute, which will ...althcare programs and initiatives that serve peopl...of AMERIGROUP Corporation and the AMERIGROUP Found...
... Affiliated Computer Services, Inc. (NYSE: ACS ...h Health Savings Account (HSA) administration serv...lect counties of Washington. Regence members will .../Intermountain region, ACS now offers the ACS HSA ...
...The Netherlands, January 12 , - Small and Com...care and,Hospitality , With the introduction o...nd easily wearable wireless messaging device, NEC ...com.com/cgi-bin/prnh/20090112/333834 ) , The ...
...ne, the only publication of its kind aimed at heal...12 HealthCare Insight(R) (HCI), a Verisk HealthCa...fraud, abuse, and overpayment prevention solutions...rehensive publication dedicated to helping public ...
Other Medicine News:Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:Nippon Life Benefits Partners with Best Doctors to Help Members Make More Informed Health Care Decisions 2Health News:Nippon Life Benefits Partners with Best Doctors to Help Members Make More Informed Health Care Decisions 3Health News:AMERIGROUP to Establish Public Policy Institute 2Health News:AMERIGROUP to Establish Public Policy Institute 3Health News:ACS to Provide HSA Product to Regence; ACS HSA Solution Now Offered by Blue Cross Blue Shield Plans in 28 States 2Health News:NEC's new M155 Messenger Sets New Standards in Mobile Messaging 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2
(Date:12/1/2009)...Dec. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (...ical products in China, announced today that,it ha...vaccine, PANFLU.1(TM),from China,s Ministry of In...,purchase plan. Under this purchase order, Sinovac...doses of PANFLU.1 (TM) (15ug/0.5ml) for the Chines...
(Date:12/1/2009)...ec. 1 Sagent Pharmaceuticals, Inc....y, today announced the launch of two antibiotics: ...njection, USP. Both are antibiotics of the cephalo...ive and gram-negative bacteria. Sagent will launch...ent the four vial sizes launched by Sagent in July...
(Date:12/1/2009)...lif., Dec. 1 Codexis, Inc. today a...signing of its second agreement this year with Tev...est generic drug manufacturer. The new agreement ... Codexis announced an earlier agreement with Teva ...will use Codexis biocatalysis technology for key p...
Breaking Medicine Technology:Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Codexis Expands Collaboration with Teva 2Tips To Enjoy a Flu Free Holiday Season 62071 1Tips To Enjoy a Flu Free Holiday Season 62071 2Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 62067 1Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 62067 2Union Labor Life 26amp 3B VSP Vision Care Align to Offer Vision Insurance Products 62063 1Union Labor Life 26amp 3B VSP Vision Care Align to Offer Vision Insurance Products 62063 2
...I) (Nasdaq and MTA: CTIC) announced that data from...pixantrone in patients with advanced, relapsed agg...nted at the 2009 American Society of Clinical Onco...m May 29 to June 2, 2009 in Orlando, Florida. , ,...niversity of London, an investigator on the study,...
...(Nasdaq: SPEX ), an innovator in biotechnology f...nd regulatory consulting services to food, supplem...oday announced that, on May 12, 2009, its Board of...omas B. Peter, to begin serving immediately. Mr. ...n and Nominating Committees. , , Spherix,s Nomina...
Other Medicine Technology:Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting 2Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting 3Spherix Elects New Independent Director, and Elects Chairman of the Board 2Spherix Elects New Independent Director, and Elects Chairman of the Board 3
ImmuGlo COMVI-ANCA (ethanol+formalin fixed)
...ditional methods for patients who are drowning in ...ic Vest effectively alleviates intervertebral comp... leg pain is,often relieved within minutes of ap...ry treatment shown to decompress the spine. Using ...
Optical Urethrotome for Telescope 1.9 mm
Optical Urethrotome for Telescope 2.7 mm
Medicine Products: